Andrew S. Davis - 02 Mar 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
02 Mar 2023
Net transactions value
-$184,653
Form type
4
Filing time
06 Mar 2023, 19:19:31 UTC
Previous filing
02 Mar 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +21,346 +22% $0.000000 119,551 02 Mar 2023 Direct F1
transaction SILK Common Stock Sale $184,653 -3,868 -3.2% $47.74 115,683 06 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.